United Kingdom: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Why Better Maternity Care And Support Matters
The publication of Donna Ockenden's final report into maternity services at Nottingham University Hospitals NHS Trust has brought to light systemic issues in communication, patient safety, and accountability that extend far beyond a single institution. With maternity claims representing 57% of new clinical negligence claims by value and costing the NHS £1.3 billion annually, the question arises: how can improved communication and mental health support during the perinatal period prevent both devastatin
United Kingdom Healthcare
Bond Turner
Article
Lessons From The Ethan Hanson Prevention Of Future Deaths Report: Communication Failures, Neurodiversity And Patient Safety
The tragic death of eight-year-old Ethan Michael Hanson has led to a Prevention of Future Deaths report exposing critical failures in NHS communication systems, neurodivergent patient assessment, and emergency care pathways. How did systemic breakdowns between primary and secondary care, combined with inadequate safeguards for recording clinical observations, contribute to a missed diagnosis of appendicitis that proved fatal?
United Kingdom Healthcare
Bond Turner
Article
Where Are The Teeth? Accountability Without Enforcement In NHS Maternity Care
The publication of Baroness Amos's final report and the appointment of a national Maternity and Neonatal Commissioner have reignited a fundamental question that has plagued NHS maternity services for years. With multiple layers of oversight already in place—from regulators and commissioners to national bodies—why does avoidable harm persist, and who actually holds the power to enforce the changes needed to prevent it?
United Kingdom Healthcare
Bond Turner
Article
The Amos Report: Another Inquiry Or Real Catalyst For Change?
The Amos Report examines whether this latest inquiry into UK maternity care will finally drive meaningful improvement or simply repeat lessons already identified by previous investigations. With decades of warnings about avoidable harm, persistent inequalities, and failures to learn from past mistakes, the report raises critical questions about systemic accountability and the effectiveness of reform efforts. Will this become another report that gathers dust, or a genuine catalyst for safer, more equitable m
United Kingdom Healthcare
Bond Turner
See more
Article
Courts Deploy Dynamic Blocking Order To Combat Counterfeit Medicines
The UK High Court has approved a groundbreaking dynamic blocking mechanism that allows pharmaceutical companies to block websites selling counterfeit medicines without requiring repeated court applications. This novel approach enables rights holders to self-certify breaches and directly instruct Internet Service Providers to block qualifying websites, marking a significant evolution in combating online pharmaceutical counterfeiting. The decision extends website blocking orders beyond traditional copyright e
United Kingdom IP
M
Matheson
Article
Excipient Or Active Ingredient? Look To The Marketing Authorisation…
The Advocate General has delivered a decisive opinion on whether a substance classified as an excipient in a marketing authorisation can be considered an active ingredient for Supplementary Protection Certificate eligibility purposes. This non-binding opinion addresses Halozyme's attempts to obtain SPC protection for a combination involving a substance designated as an excipient, with potentially far-reaching implications for pharmaceutical patent strategy and the relationship between regulatory classificat
United Kingdom IP
HL
HGF Ltd
Article
Injectable Cancer Immunotherapies: New Innovations Shortening Treatment Times And Reducing Costs
The NHS is now offering an injectable form of Keytruda (pembrolizumab) that can be administered in under two minutes, dramatically reducing treatment times from over an hour. This advancement, following last year's introduction of injectable nivolumab, promises to save hundreds of thousands of hours annually while cutting costs and improving patient care across cancer treatment services.
United Kingdom Healthcare
B
Boult Wade Tennant
See more
Article
Excipient Or Active Ingredient? Look To The Marketing Authorisation…
The Advocate General has delivered a decisive opinion on whether a substance classified as an excipient in a marketing authorisation can be considered an active ingredient for Supplementary Protection Certificate eligibility purposes. This non-binding opinion addresses Halozyme's attempts to obtain SPC protection for a combination involving a substance designated as an excipient, with potentially far-reaching implications for pharmaceutical patent strategy and the relationship between regulatory classificat
United Kingdom IP
HL
HGF Ltd
See more
Article
Client Accused Of Making Threats To Kill - Case Closed
An elderly man caring for his seriously ill wife was accused of making threats to kill her in front of paramedics, leading to his arrest and separation from his spouse of over 40 years. Despite a previous similar incident, expert legal intervention successfully demonstrated that his words were born of desperation rather than genuine intent. Through strategic representations to the Crown Prosecution Service highlighting the exceptional circumstances, the case was ultimately dropped, allowing the devoted coup
United Kingdom Criminal
Mary Monson Solicitors
Article
Why Better Maternity Care And Support Matters
The publication of Donna Ockenden's final report into maternity services at Nottingham University Hospitals NHS Trust has brought to light systemic issues in communication, patient safety, and accountability that extend far beyond a single institution. With maternity claims representing 57% of new clinical negligence claims by value and costing the NHS £1.3 billion annually, the question arises: how can improved communication and mental health support during the perinatal period prevent both devastatin
United Kingdom Healthcare
Bond Turner
Article
Lessons From The Ethan Hanson Prevention Of Future Deaths Report: Communication Failures, Neurodiversity And Patient Safety
The tragic death of eight-year-old Ethan Michael Hanson has led to a Prevention of Future Deaths report exposing critical failures in NHS communication systems, neurodivergent patient assessment, and emergency care pathways. How did systemic breakdowns between primary and secondary care, combined with inadequate safeguards for recording clinical observations, contribute to a missed diagnosis of appendicitis that proved fatal?
United Kingdom Healthcare
Bond Turner
See more